RELN and Alzheimer disease: By describing a novel mechanism of early AD based on specific molecular, cellular, and network-level changes, we aim to facilitate translational AD research in three different ways: (i) defining where the reelin signaling needs to be restored within the central nervous system; (ii) finding new molecular targets; and (iii) increasing the efficiency of psychometric tests used for early diagnosis.